Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · IEX Real-Time Price · USD
41.11
+0.28 (0.69%)
At close: Apr 26, 2024, 4:00 PM
41.00
-0.11 (-0.27%)
After-hours: Apr 26, 2024, 4:29 PM EDT
Amphastar Pharmaceuticals Revenue
In the year 2023, Amphastar Pharmaceuticals had annual revenue of $644.40M with 29.14% growth. Revenue in the quarter ending December 31, 2023 was $178.11M with 31.91% year-over-year growth.
Revenue (ttm)
$644.40M
Revenue Growth
+29.14%
P/S Ratio
3.12
Revenue / Employee
$365,926
Employees
1,761
Market Cap
2.01B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 644.40M | 145.41M | 29.14% |
Dec 31, 2022 | 498.99M | 61.22M | 13.98% |
Dec 31, 2021 | 437.77M | 87.92M | 25.13% |
Dec 31, 2020 | 349.85M | 27.49M | 8.53% |
Dec 31, 2019 | 322.36M | 27.69M | 9.40% |
Dec 31, 2018 | 294.67M | 54.49M | 22.69% |
Dec 31, 2017 | 240.18M | -14.99M | -5.87% |
Dec 31, 2016 | 255.17M | 3.65M | 1.45% |
Dec 31, 2015 | 251.52M | 41.06M | 19.51% |
Dec 31, 2014 | 210.46M | -19.22M | -8.37% |
Dec 31, 2013 | 229.68M | 25.36M | 12.41% |
Dec 31, 2012 | 204.32M | 85.97M | 72.63% |
Dec 31, 2011 | 118.36M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
agilon health | 4.32B |
CONMED | 1.26B |
TG Therapeutics | 233.66M |
RxSight | 89.08M |
Kymera Therapeutics | 78.59M |
Intellia Therapeutics | 36.28M |
NewAmsterdam Pharma Company | 15.66M |
Keros Therapeutics | 151.00K |
AMPH News
- 26 days ago - Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference - Accesswire
- 7 weeks ago - Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference - Accesswire
- 2 months ago - Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023 - Accesswire
- 2 months ago - Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024 - Accesswire
- 4 months ago - Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Accesswire
- 5 months ago - Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference - Accesswire
- 6 months ago - Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - Accesswire
- 6 months ago - Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023 - Accesswire